Accessibility Statement Skip Navigation
  • Resources
  • Data Privacy
  • Contact Us
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Guaranteed Paid Placement
    • Cision Media Monitoring
    • Multichannel Amplification
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Partnerships
    • Media Inquiries
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • All Multimedia

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Accessories
      • Computer Hardware
      • Computer Networks
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High-Tech Security
      • Internet Technology
      • Nanotechnology
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art, Culture & Design
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Projections or Forecasts
      • Financing Agreements
      • Insurance
      • Investment Options
      • Joint Ventures
      • Mutual Funds
      • Offerings
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing/marketing agreements
      • New Products & Services
      • Obituary
      • Outsourcing Businesses
      • Overseas Real Estate (Non-US)
      • Personnel Announcements
      • Residential Real Estate
      • Small-Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Accessories
      • Computer Electronics
      • Computer Hardware
      • Computer Networks
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Design Automation
      • Financial Technology
      • Mobile Devices/Apps
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Natural Gas Utilities
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Computer Accessories
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Computer Accessories
      • Computer Networks
      • Mobile Devices/Apps
      • Telecommunications
      • Telecommunications Carriers & Services
      • Telecommunications Equipment
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wine & Spirits
      • Beverages
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art, Culture & Design
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infectious Disease Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental Products & Services
      • European Government
      • Natural Disasters
      • Not-for-Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Children-related news
      • Disabled Persons
      • Diversity, Equity & Inclusion
      • Hispanic-oriented news
      • LGBTQ+
      • Religion
      • Senior Citizens
      • Veterans
      • Women-Related news
      • View All People & Culture

  • Overview
  • Distribution by PR Newswire
  • Guaranteed Paid Placement
  • Cision Media Monitoring
  • Multichannel Amplification
  • All Products
  • General Inquiries
  • Request a Demo
  • Partnerships
  • Media Inquiries
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring Home
  • Send a Release
    • Chat

    • ALL CONTACT INFO
    • Contact Us


  • News Releases
  • Send a Release
  • Data Privacy
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • News Releases
  • Send a Release
  • Data Privacy
  • Overview
  • Distribution by PR Newswire
  • Guaranteed Paid Placement
  • Cision Media Monitoring
  • Cision IR
  • SocialBoost
  • All Products
  • News Releases
  • Send a Release
  • Data Privacy
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • News Releases
  • Send a Release
  • Data Privacy

Duke-NUS marks 20 years with transformative S$30m in philanthropic gifts and pledges to boost next-gen medical breakthroughs


News provided by

Duke-NUS Medical School

11 Jan, 2025, 22:15 CST

Share this article

Share toX

Share this article

Share toX

  • The legacy of Duke-NUS' founding donor, the Estate of Khoo Teck Puat, continues with a transformative S$5.5 million gift towards research.
  • The HEAD Foundation steps up with a S$200,000 scholarship, underpinning Duke-NUS' commitment to developing medical expertise.

SINGAPORE, Jan. 11, 2025 /PRNewswire/ -- Duke-NUS Medical School celebrated its 20th anniversary with a significant philanthropic milestone, securing more than S$30 million in funding that will enrich advanced medical research and education. These contributions reflect the community's strong support for Duke-NUS' leading role in medical innovation and education.

Continue Reading
(Standing, from left to right) Mrs Fang Ai Lian, Prof Tan Ser Kiat, Mr Tony Chew and Prof Tan Chorh Chuan
(Seated, from left to right) Mr Cheung Wai Keung, Mr Goh Yew Lin, Minister Ng Eng Hen, Prof Thomas Coffman, Prof Tan Eng Chye and Prof Ng Wai Hoe
Credit: Duke-NUS Medical School
(Standing, from left to right) Mrs Fang Ai Lian, Prof Tan Ser Kiat, Mr Tony Chew and Prof Tan Chorh Chuan (Seated, from left to right) Mr Cheung Wai Keung, Mr Goh Yew Lin, Minister Ng Eng Hen, Prof Thomas Coffman, Prof Tan Eng Chye and Prof Ng Wai Hoe Credit: Duke-NUS Medical School

The philanthropic achievements at tonight's gala paved the way for future innovations and medical breakthroughs. A major highlight was the S$5.5 million donation from the Estate of Khoo Teck Puat, our most significant benefactor with a history of contributing S$80 million to the School in 2007.

Of this latest donation, S$3.5 million will go to the Khoo Teck Puat Translational Research Fund to support projects with significant potential to be translated into clinical applications such as effective medical therapies and/or drugs.

The inaugural project will focus on developing new tools for diagnosing cardiometabolic diseases and funding metabolomics research headed by Professor Wang Yibin, Director of Duke-NUS' Cardiovascular & Metabolic Disorders programme. With limited therapeutic options currently available, the gift will be critical to the development of a state-of-the-art metabolism research centre in the School. It will also support Professor Wang and his team in acquiring top-notch technology and recruiting top-tier researchers to develop novel diagnostic tools and targeted treatments for cardiometabolic diseases.

Minister for Defence Dr Ng Eng Hen, the gala's guest-of-honour, said of Duke-NUS' journey and impact:

"As in 2005, when Duke-NUS was born, I have that same confidence that Duke-NUS will achieve even greater things going forward. Your faculty and staff will continue to be pacesetters for many fields of medicine and public health. Your students and graduates will excel, distinguishing themselves with their talents and passion. Your doctors will add health and wealth to living for Singaporeans and the wider region."

Ms Mavis Khoo, speaking on behalf of the Estate of Khoo Teck Puat, reflected on the impact of her family's contributions:

"My late father believed passionately that advances in education, healthcare and medical research will make a substantial difference to the lives of people in Singapore and around the world. We are very proud of Duke-NUS' achievements over the years, and are confident that the School will continue to break new grounds in the treatment of diseases, thus benefiting current and future generations."

The School also received a pledge of US$20 million (approximately S$27.4 million) to advance cutting-edge translational genomic research in the next two to three years, with local and international partners.

Additional significant contributions include The HEAD Foundation's S$200,000 scholarship, which will support MD students with funds that can be used towards tuition fees and living expenses, further underscoring Duke-NUS' dedication to fostering the next generation of medical professionals.

Mr Lim Yu Book, Director of The HEAD Foundation, shared the foundation's vision for the scholarship:

"The HEAD Foundation Scholarship aims to provide meaningful support for Duke-NUS students, fuelling their journey to become impactful medical professionals. As we celebrate Duke-NUS' 20th anniversary, this scholarship underscores our commitment to fostering a new generation of doctors dedicated to transforming patient care and community health." 

Mr Goh Yew Lin, Chairman of the Duke-NUS Governing Board, reflected on the School's journey and its bright future:

"From its inception, Duke-NUS was envisioned as a beacon of medical excellence and innovation. Thanks to the unwavering support of our donors, like the Estate of Khoo Teck Puat and many others, we have been able to make that vision a reality. These generous contributions not only empower our continued leadership in biomedical sciences but also ensure we remain at the forefront of medical education and research."

Professor Thomas Coffman, Dean of Duke-NUS, added:

"The generous gifts from our donors underscore the confidence and commitment of our community towards advancing human health. These funds will significantly enhance our research capabilities, enabling our researchers to make impactful discoveries that can lead to better patient outcomes worldwide, while we continue to provide top-tier medical education."

The fundraiser celebrated and strategically advanced Duke-NUS' initiatives in medical education and research. Highlighting the School's innovative approach, the evening included an engaging segment with TwoSet Violin, blending art with discourse in medical science.

As Duke-NUS anticipates many more decades of excellence and innovation, the ongoing support from philanthropists and our community will be crucial in propelling the next wave of medical breakthroughs and educational advancements.

About Duke-NUS Medical School

Duke-NUS is Singapore's flagship graduate entry medical school, established in 2005 with a strategic, government-led partnership between two world-class institutions: Duke University School of Medicine and the National University of Singapore (NUS). Through an innovative curriculum, students at Duke-NUS are nurtured to become multi-faceted 'Clinicians Plus' poised to steer the healthcare and biomedical ecosystem in Singapore and beyond. A leader in ground-breaking research and translational innovation, Duke-NUS has gained international renown through its five Signature Research Programmes and ten Centres. The enduring impact of its discoveries is amplified by its successful Academic Medicine partnership with Singapore Health Services (SingHealth), Singapore's largest healthcare group. This strategic alliance has led to the creation of 15 Academic Clinical Programmes, which harness multi-disciplinary research and education to transform medicine and improve lives.   

For more information, please visit www.duke-nus.edu.sg 

SOURCE Duke-NUS Medical School

Modal title

Also from this source

Career-switching professionals, twins and trailblazers: Duke-NUS' Class of 2029 redefines path to medicine

Career-switching professionals, twins and trailblazers: Duke-NUS' Class of 2029 redefines path to medicine

A new chapter in Singapore's healthcare story began today as 78 aspiring doctors from Duke-NUS Medical School's 19th Doctor of Medicine (MD) cohort...

Duke-NUS celebrates 20 years of medical innovation with largest ever graduating class

Duke-NUS celebrates 20 years of medical innovation with largest ever graduating class

Celebrating 20 years of transformative medical education, Duke-NUS Medical School graduated its largest cohort yet today, the Class of 2025, in a...

More Releases From This Source

Explore

Education

Education

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact Cision

  • General Inquiries
  • Request a Demo
  • Partnerships
  • Media Inquiries

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Careers
  • Accessibility Statement
  • APAC – Simplified Chinese
  • APAC
  • APAC - Traditional Chinese
  • Arabic
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
  • Vietnam

My Services

  • All New Releases
  • Platform

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Platform
[email protected]
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
  • Accessibility
Copyright © 2025 Cision US Inc.